Back
ProShares UltraShort 20+ Year Treasury Vs. PTC Therapeutics Industry Stock Comparison
Sell
44
TBT
ProShares UltraShort 20+ Year Treasury
Last Price:
33.26
Seasonality Move:
-5.03%
Sell
47
PTCT
PTC Therapeutics
Last Price:
34.68
Seasonality Move:
8.27%
Sell
44
ProShares UltraShort 20+ Year Treasury (TBT)
is a Sell
Is ProShares UltraShort 20+ Year Treasury a Buy, Sell or Hold?
- The current ProShares UltraShort 20+ Year Treasury [TBT] share price is $33.50. The Score for TBT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- TBT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $35.04. The Score for PTCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBT Stock Price Chart
What is ProShares UltraShort 20+ Year Treasury's stock price today?
-
The ProShares UltraShort 20+ Year Treasury share price today is $33.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBT is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $35.04
The current trend is moderately bearish and PTCT is experiencing slight buying pressure.
TBT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.65 | Sell |
| Relative Strength Index (14 RSI): | 43.65 | Sell |
| Chaikin Money Flow: | 254048 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.25 - 35.79) | Sell |
| Bollinger Bands (100): | (33.2 - 36.32) | Sell |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 48.37 | Sell |
| Chaikin Money Flow: | 135092 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.32 - 37.86) | Sell |
| Bollinger Bands (100): | (26.42 - 35.08) | Buy |
TBT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.2 | Buy |
| 20-day SMA: | 34.27 | Sell |
| 50-day SMA: | 35.57 | Sell |
| 200-day SMA: | 35.51 | Sell |
| 8-day EMA: | 33.42 | Buy |
| 20-day EMA: | 34.04 | Sell |
| 50-day EMA: | 34.73 | Sell |
| 200-day EMA: | 34.4 | Sell |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.32 | Sell |
| 20-day SMA: | 36.32 | Sell |
| 50-day SMA: | 33.48 | Buy |
| 200-day SMA: | 27.73 | Buy |
| 8-day EMA: | 35.54 | Sell |
| 20-day EMA: | 35.73 | Sell |
| 50-day EMA: | 34.06 | Buy |
| 200-day EMA: | 31.81 | Buy |
ProShares UltraShort 20+ Year Treasury Earnings Growth & TBT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.10 per share, an increase this year of $0.53 per share, and an increase next year of $2.08 per share.
ProShares UltraShort 20+ Year Treasury Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||